Navigation Links
Shaklee Hits the Road With Its Infinite Possibilities Tour
Date:2/3/2009

Nationwide tour to impact the lives of one million families by offering an economic opportunity in these tough economic times

PLEASANTON, Calif., Feb. 3 /PRNewswire/ -- Shaklee Corporation Chairman and CEO Roger Barnett will launch a nationwide campaign to promote an opportunity that offers economic support to one million families in 2009. The campaign will kick off February 9 in Greensboro, NC.

"Families are struggling to make ends meet in this difficult economy," says Barnett. "While so many others are cutting back, we're a 50-year-old company with a revolutionary business model that's seeking to create one million new entrepreneurial opportunities to give people the potential to thrive even during these difficult economic times."

"Shaklee has actually grown during the past seven economic downturns. Our economic growth, combined with products that make people and the planet healthier, make Shaklee a powerful force for good," says Barnett.

The tour comes at a time when the economic crisis is growing both in the United States and the rest of the world. According to the Bureau of Labor Statistics, almost 2.4 million people in the US have lost their jobs in 2008 alone, which brings the total number of unemployed to 11.1 million, with unemployment levels expected to rise throughout 2009. Shaklee offers an entrepreneurial opportunity to supplement earnings with part-time income, or to develop a full-time income.

Founded in 1956, Shaklee Corporation is the leading natural nutrition company in the United States. It has paid out more than $4 billion in total commissions to millions of people around the world. The company's innovative product portfolio includes proprietary nutrition -- including a revolutionary cellular anti-aging supplement called Vivix(TM) -- as well as healthy weight-management, healthy beauty products, and healthy home products. Shaklee has been an environmental pioneer for decades and was the first company in the world to be Climate Neutral(TM) certified to totally offset its carbon emissions, resulting in a net-zero impact on the environment.

"We're in the business of doing well by doing good," says Barnett. "I strongly believe that, through our network of educators and business leaders, we can empower people to live healthier lives while taking care of their families and the planet."

The nationwide tour will run through Feb. 14 and is free and open to the public. For information on this campaign, call 1-800-SHAKLEE.

Tour dates:

Greensboro, NC -- February 9

New York City, NY -- February 10 (Spanish translation provided)

Chicago, IL -- February 11 (Spanish translation provided)

Dallas, TX -- February 12

Denver, CO -- February 13

Los Angeles, CA -- February 14 (Spanish language provided)

About Shaklee Corporation

Founded over 50 years ago, Shaklee has been a leading provider of premium-quality natural nutrition products, personal care products, environmentally friendly household products, and state-of-the-art air and water treatment systems. In 2000, Shaklee became the first company in the world to be Climate Neutral(TM) certified to totally offset its CO2 emissions, resulting in a net-zero impact on the environment. With a robust product portfolio, including over 50 patents and patents pending worldwide, Shaklee has more than 750,000 Members and Distributors worldwide and operates in the U.S., Mexico, Canada, Japan, Malaysia, Taiwan, and China. For information about Shaklee, visit Shaklee.com.


'/>"/>
SOURCE Shaklee Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shaklee China Opens Beijing Headquarters
2. Shaklee Partners With U.S. Ski Team and U.S. Snowboarding in Preparation for the 2010 Games in Vancouver
3. Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment
4. New possibilities for breast cancer treatment on the horizon
5. A new world of research possibilities with Emerging Model Organisms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... DC (PRWEB) , ... April ... ... Association (ATA) is thrilled to announce the ATA 2017 President’s Awards recipients, ... innovation and demonstrated superior healthcare delivery. , The ATA 2017 President’s ...
(Date:4/26/2017)... ... , ... Infertility may be a result of an underlying ... women become pregnant upon treating their diagnosis. , To properly diagnose ... We can provide the necessary information to diagnose and treat your problem. ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... ecosystem and domain expertise for sponsors and CROs to speed clinical development, ... management (RTSM) software platform. Bioclinica AGILE RTSM provides seamless clinical ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology: